| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |